Feasibility Study of Sleep Endoscopy Under Hypnosis in a Sleep Center
Launched by ELSAN · Oct 21, 2021
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient, women or men over 18 years old
- • Moderate obstructive sleep apnea syndrome (Hypopnea apnea index between 15 and 30) without any serious sign
- • Simple Ronchopathy
- • Indication of video-fibroscopy of upper airways
- • Affiliated subject or beneficiary of a social security scheme
- • Patient having signed the free and informed consent
- Exclusion Criteria:
- • Psychiatric disorders that can be decompensated by hypnosis (bipolarity, schizophrenia, ...)
- • Smoking less than 10 cigarettes per day
- • Alcoholism, chronic or serious disabling pathology
- • Medical history of cancer of upper airways, radiotherapy
- • Pregnancy
- • Recent supper airway infection, rhinosinusitis
- • Active allergy
- • Non-obstructive sleep apnea syndrome
- • severe non-obstructive sleep apnea syndrome (Hypopnea apnea index\> 30)
- • Dental contraindication to mandibular advancement device
- • Intolerance or allergy to local anesthesia with Xylocaine spray 5% known
- • Refusal to participate in the study
- • Protected patients: adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- • Pregnant, breastfeeding or parturient woman
- • Hospitalized without consent
About Elsan
Elsan is a leading healthcare organization specializing in the management and operation of private medical facilities, with a strong focus on enhancing patient care and clinical outcomes. With a commitment to innovation and excellence, Elsan conducts clinical trials that advance medical research and treatment options across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and researchers to ensure rigorous study design and ethical standards, ultimately aiming to contribute valuable insights to the medical community and improve patient health on a broader scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Potiers, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials